NCT07303270 Emotional Processes in Adults With Intellectual Developmental Disorder
| NCT ID | NCT07303270 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hôpital le Vinatier |
| Condition | Intellectual Developmental Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-02-19 |
| Primary Completion | 2028-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-02-19 with a primary completion date of 2028-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Emotions play a crucial part in the quality of life, interpersonal relationships and mental health in general. In adults presenting with intellectual developmental disorder (IDD), emotional abilities may be hindered, thus leading to more challenging behaviors. A better understanding of emotional processes of adults with IDD may help improve the efficiency of behavioral interventions and better improve their quality of life. The primary goal of this study is to better characterize the abilities and weaknesses of adults with IDD concerning their emotional processes, in comparison to a healthy population. The secondary goals are : * to determine if these difficulties are underlined by oculomotor and attention (auditory and visual) processes * to determine if behavioral difficulties, as reported by the families of adults with IDD, are underlined by specific difficulties in facial emotion recognition, emotion identification in context and/or identification of vocal emotions.
Eligibility Criteria
Inclusion Criteria: IDD group : * Diagnosis of IDD according to DSM-V criteria * aged between 18 and 3 years * French speaking * Membership or entitlement to a social security plan * informed consent, or that of the tutor, to take part in the study * presence of a caregiver to complete the questionnaires at V2. Control group : * aged between 18 and 35 years * French speaking * Membership or entitlement to a social security plan * Informed written consent to take part in the study. Exclusion Criteria: IDD group : * visual or auditory impairments, evaluated at V1 * non stabilized epilepsy * undergoing treatments that can impact brain or psychological functioning * major motor disorders * breastfeeding or pregnant woman Control group : * neurodevelopmental or psychiatric disorder * history of brain trauma (TBI, stroke, etc…) or non-stabilized epilepsy * visual or auditory impairments, evaluated at V1 * non stabilized epilepsy * undergoing treatments that can impact brain or psychological functioning * major motor disorders * breastfeeding or pregnant woman
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07303270 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Intellectual Developmental Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07303270 currently recruiting?
Yes, NCT07303270 is actively recruiting participants. Contact the research team at marie-noelle.babinet@ch-le-vinatier.fr for enrollment information.
Where is the NCT07303270 trial being conducted?
This trial is being conducted at Bron, France.
Who is sponsoring the NCT07303270 clinical trial?
NCT07303270 is sponsored by Hôpital le Vinatier. The trial plans to enroll 60 participants.